KHKeri Hurley-Kim

Keri Hurley-Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Keri Hurley-Kim has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Associations between long-term metformin use, the risk of vitamin B12 deficiency, and neuropathy: An All of Us research Program study

    by Aryana Sepassi, Jiayuan Wang, Sophia Yankowski, Aya Enkoji, Mmeridi Okenwa, Candis M. Morello, Keri Hurley-Kim


  • Open Access

    Pharmacist-Managed Refill Service Impacts on Clinician Workload and Medication Interventions in a Federally Qualified Health Center

    by Keri Hurley-Kim, Azin Keyvani, Raed Ahmed, Hei-Wah Wong, Sarah McBane

    Introduction: Increasing administrative workload is linked with lower quality of patient care and physician burnout. Conversely, models involving pharmacists can positively impact patient care and physician well-being. Research has consistently demonstrated that pharmacist-physician collaboration can improve outcomes for chronic diagnoses. Pharmacist-managed refill services may improve provider workload measures and clinical outcomes. Methods: This was an evaluation of a pharmacist-managed refill service at a Federally Qualified Health Center (FQHC). Under collaborative practice agreement, pharmacists addressed refill requests and recommended interventions. Data analysis evaluated effectiveness of the model, including clinical interventions, and involved descriptive statistics and qualitative approaches. Results: Average patient age was 55.5 years old and 53.1% were female. Turnaround time was within 48 h for 87.8% of refill encounters. During an average of 3.2 h per week, pharmacists addressed 9.2% (n = 1683 individual requests in 1255 indirect patient encounters) of the total clinic refill requests during the 1-year study period. In 453 of these encounters (36.1%), pharmacists recommended a total of 642 interventions. 64.8% of these were need for appointment (n = 211) or labs (n = 205). Drug therapy problems and medication list discrepancies were identified in 12.6% (n = 81) and 11.9% (n = 76) of encounters, respectively. Discussion and Conclusions: The results of this study are consistent with previous literature demonstrating the value of interprofessional collaboration. Pharmacists addressed refills in an efficient, clinically effective manner in an FQHC setting. This may positively impact primary care provider workload, patients’ medication persistence, and clinical care.


  • Open Access

    Sociodemographic characteristics differ across routine adult vaccine cohorts: An All of Us descriptive study

    by Ding Quan Ng, Stanley Jia, Cheryl Wisseh, Christine Cadiz, Megan Nguyen, Joyce Lee, Sarah McBane, Lee Nguyen, Alexandre Chan, Keri Hurley-Kim


  • Worldwide characteristics and trends of pharmacist interventions contributed to minimize health disparities

    by Aya F. Ozaki, Christine L. Cadiz, Keri Hurley‐Kim, Cheryl Wisseh, Erin D. Knox, Joyce Y. Lee, Ashley Wang, Sakhi G. Patel, Alexandre Chan

    Health disparities in outcomes are ubiquitous and must be addressed. Pharmacist‐led clinical services have been shown to improve patient outcomes and reduce costs. However, their involvement in addressing health disparities has not been well documented. We conducted a literature review to summarize worldwide pharmacist‐involved interventions that contributed to reducing health disparities. The overarching goal is to provide guidance on future directions to advance health equity. PubMed, Scopus, Embase, and CINAHL were searched from inception to October 2021. Studies included were those that evaluated pharmacist‐involved interventions contributing to the mitigation of health disparities. Pilot or preliminary studies and those published in non‐English languages were excluded. Study characteristics, clinical areas, targeted patient population, types of interventions, and outcomes were evaluated. A total of 151 studies were included, of which 27% were randomized controlled trials. The majority of studies (82%) conducted in high‐income countries targeted cardiometabolic conditions (49%). Infectious diseases were commonly managed conditions among studies (56%) conducted in low‐/middle‐income countries. Most pharmacist‐involved interventions were delivered to rural communities (45%), followed by patients with low income (33%) and racial/ethnic minorities (24%). A minimal number of studies (1%) addressed gender‐ or disability‐related interventions. Multidisciplinary team care (70%) and medication management (64%) were the most prevalent care models reported among the studies, followed by education (49%) and screenings/health fairs (21%). Commonly reported outcome measures included laboratory values (38%), medication utilization (29%), and medication adherence (16%). Only 7% and 9% of the studies reported humanistic and economic outcomes, respectively. Pharmacists have been involved in a variety of clinical interventions targeting a diverse range of patient populations, which unveiled pharmacists' roles in contributing to reducing health disparities. Variability of implemented interventions exists geographically and in certain groups for whom few interventions have been implemented, highlighting the need for further efforts to achieve equity in health care.